Editorial Board — Medscape Diabetes & Endocrinology

Board Members

  • Harpreet S. Bajaj. MD, MPH
    • Research Associate
      Leadership Sinai Center for Diabetes
      Mount Sinai Hospital
      University of Toronto
      Toronto, Ontario, Canada
      Associate Endocrinologist
      LMC Diabetes & Endocrinology
      Brampton, Ontario, Canada
  • Kenneth D. Burman, MD
    • Professor
      Department of Medicine
      Georgetown University School of Medicine
      Chief Endocrine Section
      Washington Hospital Center
      Washington, DC
  • Aaron R. Chidakel, MD
    • New York University Langone Medical Center
      New York, New York
  • Cyrus V. Desouza, MBBS
    • University of Nebraska Medical Center and Nebraska Medicine
      Omaha, Nebraska
  • Vivian Fonseca, MD
    • Tulane University
      New Orleans, Louisiana
  • Per-Henrik Groop, MD, DMSc
    • University of Helsinki and Helsinki University Hospital
      Helsinki, Finland
 

Board Member Details

Harpreet S. Bajaj, MD, MPH
Harpreet S. Bajaj, MD, MPH

Research Associate, Leadership Sinai Center for Diabetes, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; Associate Endocrinologist, LMC Diabetes & Endocrinology, Brampton, Ontario, Canada

Harpreet S. Bajaj, MD, MPH, had disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Merck & Co., Inc.; Novo Nordisk; sanofi-aventis; Valeant Pharmaceuticals International; Janssen Pharmaceutical Products, L.P.; Amgen Inc.
Serve(d) as a speaker or a member of a speakers bureau: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals; Bayer HealthCare Pharmaceuticals; Eli Lilly and Company; Janssen Pharmaceutical Products, L.P; Merck & Co., Inc.; Novo Nordisk; sanofi-aventis; Amgen Inc.
Received research grant from: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company; Janssen Pharmaceutical Products, L.P; Merck & Co., Inc.; Novo Nordisk; Pfizer Inc; sanofi-aventis; Valeant Pharmaceuticals International
Received income in an amount equal to or great than $250 from: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Merck & Co., Inc.; Novo Nordisk; sanofi-aventis; Valeant Pharmaceuticals International; Janssen Pharmaceutical Products, L.P.; Amgen Inc.; Bayer HealthCare Pharmaceuticals; Pfizer Inc

Kenneth D. Burman, MD

Professor, Department of Medicine, Georgetown University School of Medicine; Chief Endocrine Section, Washington Hospital Center, Washington, DC

Kenneth D. Burman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Liotridev LLC
Received research grant from: AstraZeneca Pharmaceuticals LP; Eisai Inc. (clinical trials)
Received income in an amount equal to or greater than $250 from: UpToDate

Aaron R. Chidakel, MD
Aaron R. Chidakel, MD

Assistant Clinical Professor, New York University Langone Medical Center, New York, New York

Aaron R. Chidakel, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: AbbVie, sanofi-aventis, Boehringer Ingelheim Pharmaceuticals, Inc.

Cyrus V. Desouza, MBBS
Cyrus V. Desouza, MBBS

Professor, University of Nebraska Medical Center; Professor & Schulz Professor of Diabetes Research (Division Chief), Nebraska Medicine, Omaha, Nebraska

Cyrus V. Desouza, MBBS, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk

Vivian Fonseca, MD
Vivian Fonseca, MD

Professor of Medicine, Tulane University, New Orleans, Louisiana

Vivian Fonseca, MD, has disclosed the following relevant financial relationships:
Received research support (to Tulane): Grants from Asahi; Bayer HealthCare Pharmaceuticals
Honoraria for consulting and lectures: Takeda Pharmaceuticals North America, Inc; Novo Nordisk; sanofi-aventis; Eli Lilly and Company; AstraZeneca; Intarcia

Per-Henrik Groop, MD, DMSc
Per-Henrik Groop, MD, DMSc

Professor, University of Helsinki; Chief Physician, Helsinki University Hospital, Abdominal Center Nephrology, Biomedicum Helsinki, Helsinki, Finland

Per-Henrik Groop, MD, DMSc, has disclosed the following relevant financial relationships:
Serve(d) as an advisor during the last 6 years for: AbbVie Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Janssen Pharmaceutical Products, L.P.; Medscape, LLC; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Novo Nordisk; sanofi-aventis
Serve(d) as a speaker during the last 6 years for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Genzyme Corporation; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Novo Nordisk; sanofi-aventis
Received investigator-initiated research grant from: Eli Lilly and Company; Roche
Received income in an amount equal to or greater than $250 during the last 6 years from: AbbVie Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Genzyme Corporation; Janssen Pharmaceutical Products, L.P.; Medscape, LLC; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Novo Nordisk; sanofi-aventis

Simon R. Heller, MB BChir, DM, FRCP
Simon R. Heller, MB BChir, DM, FRCP

Professor of Clinical Diabetes, Department of Oncology and Metabolism, University of Sheffield School of Medicine; Honorary Consultant Physician, Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals Foundation Trust, Sheffield, South Yorkshire, United Kingdom

Simon R. Heller, MB BChir, DM, FRCP, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Eli Lilly and Company; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.
Serve(d) as a speaker or member of a speakers bureau for: Eli Lilly and Company; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.; Merck Sharp & Dohme Corp.; AstraZeneca Pharmaceuticals LP
Received research grant from: Medtronic UK Ltd

Scott Kahan, MD, MPH

Faculty, Department of Health Policy and Management, Johns Hopkins University; Faculty, School of Public Health; Director, National Center for Weight and Wellness, Medical Director, Strategies to Overcome and Prevent (STOP) Obesity Alliance, George Washington University, Washington, DC

Scott Kahan, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Novo Nordisk; Orexigen; Eisai; Rhythm; KVK Tech

Anne L. Peters, MD
Anne L. Peters, MD, CDE

Professor, Department of Endocrinology, Director, University of Southern California Clinical Diabetes Program, Keck School of Medicine, University of Southern California, Los Angeles, California

Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Abbott Diabetes Care; Becton, Dickinson and Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; ; Merck & Co., Inc.; Janssen Pharmaceuticals, Inc; Lexicon; Medscape; Novo Nordisk; Omada Health; OptumRx; Perrigo; Roche; sanofi
Serve(d) as a speaker or a member of a speakers bureau for: Abbott Diabetes Care; Becton, Dickinson and Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; ; Merck & Co., Inc.; Janssen Pharmaceuticals, Inc; Lexicon; Medscape; Novo Nordisk; Omada Health; OptumRx; Perrigo; Roche; sanofi
Received a research grant from: Dexcom
Received income in an amount equal to or greater than $250 from: Abbott Diabetes Care; Becton, Dickinson and Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; ; Merck & Co., Inc.; Janssen Pharmaceuticals, Inc; Lexicon; Medscape; Novo Nordisk; Omada Health; OptumRx; Perrigo; Roche; Sanofi

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC
Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC

Professor of Medicine, Chair of Obesity Research & Management, University of Alberta; Royal Alexandra Hospital, Weight Wise Clinic, Edmonton, Alberta

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk; Zalgen Labs; Vivus, Inc.; Takeda Pharmaceuticals North America, Inc.; Ethicon, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Novo Nordisk; Zalgen Labs; Vivus, Inc.; Takeda Pharmaceuticals North America, Inc.; Ethicon, Inc.

Dace L. Trence, MD
Dace L. Trence, MD

Professor, Director, Diabetes Care Center, Director, Endocrine Fellowship, University of Washington, Seattle

Dace Trence, MD, has disclosed no relevant financial relationships.